GlassScriptPhysician profile
Charles A Kinder
NPI 1346204518
$163,526.46
in general payments reported to CMS, 2019-2025
36 companies · $1,479 in 2025
The $1,479 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65K · 2020: $22K · 2021: $10K · 2022: $24K · 2023: $21K · 2024: $20K · 2025: $1,479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $34K · Food and Beverage: $5,009 · Travel and Lodging: $2,470 · Consulting Fee: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $33,688.00 |
| Food and Beverage | $5,008.93 |
| Travel and Lodging | $2,470.15 |
| Consulting Fee | $1,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $78,841.52 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $77,997.89 | 2019-2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $2,083.41 | 2019-2025 | |
| Boston Scientific Corporation | $633.26 | 2019-2025 | Bodyguardian, Watchman Access System, General - Therapies |
| Elutia, INC. | $517.24 | 2021-2025 | Ecm Patch,Pouch |
| Preventric Diagnostics, INC. | $464.50 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $402.30 | 2019-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $369.06 | 2022-2023 | Assure Wcd |
| Amgen INC. | $318.01 | 2019-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $204.77 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $200.10 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $181.70 | 2023-2025 | Verquvo |
| Sanofi-Aventis U.S. LLC | $168.29 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $156.00 | 2019-2025 | Farxiga |
| Scpharmaceuticals INC. | $153.38 | 2023-2025 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $107.16 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Esperion Therapeutics, INC. | $106.01 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $92.17 | 2025 | |
| Lundbeck LLC | $82.25 | 2019-2021 | |
| Inspire Medical Systems, INC. | $69.54 | 2023-2025 | Inspire |
| Amarin Pharma, INC. | $56.29 | 2019-2021 | |
| Cvrx, INC. | $47.60 | 2024 | Barostim Neo System |
| Siemens Medical Solutions USA, INC. | $34.34 | 2023 | Cios Alpha |
| Philips North America LLC | $28.46 | 2020 | |
| Lilly USA, LLC | $22.79 | 2025 | Zepbound |
| Biotronik INC. | $21.07 | 2025 | Amvia Edge |
| Altathera Pharmaceuticals LLC | $20.36 | 2024 | Sotalol Hydrochloride |
| Chiesi USA, INC. | $19.65 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $18.51 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $18.29 | 2023 | Inpefa |
| Regeneron Healthcare Solutions, INC. | $17.93 | 2019 | |
| Edwards Lifesciences Corporation | $17.74 | 2022 | |
| Idorsia Pharmaceuticals US INC | $17.09 | 2025 | Tryvio |
| Atricure, INC. | $16.65 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Medtronic USA, INC. | $12.41 | 2019 | |
| Itamar Medical INC | $8.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Kinder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.